Morgenthaler Ventures
Portola Valley, California, United StatesFounded 1968
Morgenthaler Ventures primarily focuses on early-stage investments in information technology and life sciences companies. The firm's strategy has evolved to include seed, Series A, B, and C financing rounds.
56% of their portfolio is in Healthcare. Their most common stage is series-b (44% of deals). Average disclosed round size is $37.4M (across 9 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Relievant Medsystems | Series C | $50M | Apr 2023 |
| Relievant Medsystems | Growth | $70M | Oct 2020 |
| VViv Labs | Series B | $12.5M | Feb 2015 |
| MMuleSoft | Series C | $50M | Mar 2014 |
 Practice Fusion | Series D | $70M | Sep 2013 |
| SSocrata | Series B | $18M | Jun 2013 |
 Doximity | Series B | $17M | Sep 2012 |
| Practice Fusion | Series C | $34M | Jun 2012 |
| PPageonce | Series B | $15M | May 2011 |
Top Co-Investors
Felicis Ventures2 shared
Canaan Partners2 shared
Vensana Capital2 shared
Lightstone Ventures2 shared
Endeavour Vision2 shared
NEA (New Enterprise Associates)1 shared
Lightspeed Venture Partners1 shared
Meritech Capital1 shared
Cisco Investments1 shared
Salesforce1 shared
SAP1 shared
Kleiner Perkins Caufield & Byers1 shared
OrbiMed1 shared
Deerfield Management Company1 shared
Emergence Capital1 shared
OpenView1 shared
Frazier Group1 shared
Founders Fund1 shared
SV Angel1 shared
Band of Angels1 shared
Last updated: 8 March 2026